DHX29 and ovarian serous adenocarcinoma: However, a previous study has shown that DHX29 is overexpressed in various types of cancers, including glioblastoma multiforme, metastatic melanoma, ovarian endometrioid carcinoma and ovarian serous adenocarcinoma [41].